��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Adult Pilocytic Astrocytoma: Clinical Management and Prognostic Factors

Topic Neuro-oncology

Presentation(s) P6 - (-)

Poster/Presentation
Number 158

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Ovais Inamullah, MD (Duke University Hospital) PRESENTER	Dr. Inamullah has nothing to disclose.
	No disclosure on file
	No disclosure on file
Eric Lipp	No disclosure on file
Margaret O. Johnson, MD (Duke University Medical Center)	Dr. Johnson has nothing to disclose.
	No disclosure on file
Dina Randazzo, DO	No disclosure on file
	No disclosure on file
Katherine B. Peters, MD, PhD, FAAN (Duke University Medical Center)	Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sapience. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharmaceutical. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rigel. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nuvation. The institution of Dr. Peters has received research support from Biomimetix. The institution of Dr. Peters has received research support from Servier. The institution of Dr. Peters has received research support from Varian. The institution of Dr. Peters has received research support from Sapience. The institution of Dr. Peters has received research support from Ono Pharmaceuticals/Deciphera. The institution of Dr. Peters has received research support from Nuvation. The institution of Dr. Peters has received research support from Novocure. The institution of Dr. Peters has received research support from Curis.